WO2002008288A2
(en)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
CA2328496C
(en)
|
1998-05-15 |
2016-01-05 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
WO2000050565A2
(en)
*
|
1999-02-25 |
2000-08-31 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
EP1157038A4
(en)
*
|
1999-02-26 |
2005-01-19 |
Smithkline Beecham Corp |
CLONING OF A P2Y-LIKE 7TM RECEPTOR (AXOR17)
|
WO2000056881A1
(en)
*
|
1999-03-23 |
2000-09-28 |
Human Genome Sciences, Inc. |
48 human secreted proteins
|
CA2365601A1
(en)
|
1999-03-29 |
2000-10-05 |
Kansai Technology Licensing Organization Co., Ltd. |
Novel cytidine deaminase
|
EP1637541B1
(en)
*
|
1999-09-01 |
2010-03-03 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20020151047A1
(en)
*
|
2001-01-08 |
2002-10-17 |
Yi Hu |
Novel human protease and polynucleotides encoding the same
|
AU1238201A
(en)
*
|
1999-10-27 |
2001-05-08 |
Millennium Pharmaceuticals, Inc. |
Novel molecules and the card-related protein family and uses thereof
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
EP1878795A3
(en)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP1250426A2
(en)
*
|
1999-12-01 |
2002-10-23 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding same
|
CN1300781A
(zh)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
一种新的多肽-人shc蛋白43和编码这种多肽的多核苷酸
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
AU2001237973B2
(en)
|
2000-01-26 |
2006-09-07 |
Agensys, Inc. |
84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
US20020090705A1
(en)
*
|
2000-07-14 |
2002-07-11 |
Rachel Meyers |
62088, a novel human nucleoside phosphatase family member and uses thereof
|
US20020055159A1
(en)
*
|
2000-06-15 |
2002-05-09 |
Meyers Rachel A. |
23680,a novel human aminotransferase and uses therefor
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
AU2001250980A1
(en)
*
|
2000-03-23 |
2001-10-03 |
Carmela Beger |
Brca-1 regulators and methods of use
|
AU2001245974A1
(en)
|
2000-03-24 |
2001-10-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
JP2004511205A
(ja)
|
2000-04-25 |
2004-04-15 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトキナーゼプロテインおよびそれをコードするポリヌクレオチド
|
AU2001257407A1
(en)
*
|
2000-04-26 |
2001-11-07 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
WO2001085921A2
(en)
*
|
2000-05-12 |
2001-11-15 |
Merck Patent Gmbh |
Human serine-threonine kinase-4
|
EP1158001B1
(en)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
|
AU7634301A
(en)
*
|
2000-05-26 |
2001-12-03 |
Bayer Aktiengesellschaft |
Regulation of human p78-like serine/threonine kinase
|
DE10027170A1
(de)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Humanes PEM als Target für die Fertilitätskontrolle
|
US7098311B2
(en)
*
|
2000-06-02 |
2006-08-29 |
Brigham And Women's Hospital |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU6604901A
(en)
*
|
2000-06-05 |
2001-12-17 |
Bayer Aktiengesellschaft |
Regulation of human hm74-like g protein coupled receptor
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
EP1287029A2
(en)
*
|
2000-06-09 |
2003-03-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
WO2001096546A2
(en)
*
|
2000-06-16 |
2001-12-20 |
Incyte Genomics, Inc. |
Protein phosphatases
|
EP2075253A1
(en)
*
|
2000-06-23 |
2009-07-01 |
Genentech, Inc. |
Compositions and methds for the diagnosis and treatment of disorders involving angiogensis
|
WO2002000861A2
(en)
*
|
2000-06-26 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
Human beta-ketoacyl synthase (46619) and uses thereof
|
AU2001270215A1
(en)
*
|
2000-06-27 |
2002-01-08 |
Curagen Corporation |
Novel polynucleotides and polypeptides encoded thereby
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
US6774223B2
(en)
|
2000-06-28 |
2004-08-10 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
WO2002002761A2
(en)
*
|
2000-06-30 |
2002-01-10 |
Millennium Pharmaceuticals, Inc. |
57658, a human uridine kinase and uses thereof
|
AU2001271843A1
(en)
*
|
2000-07-07 |
2002-01-21 |
Incyte Genomics, Inc. |
Gtp-binding proteins
|
AU2001273239A1
(en)
*
|
2000-07-07 |
2002-01-21 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
EP1303620A2
(en)
*
|
2000-07-18 |
2003-04-23 |
Bayer Aktiengesellschaft |
Regulation of human desc1-like serine protease
|
US6740751B2
(en)
|
2000-07-18 |
2004-05-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
|
AU8762901A
(en)
*
|
2000-07-25 |
2002-02-05 |
Merck Patent Gmbh |
Novel protein containing ring finger domaine r1p4
|
AU2001277202A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
AU2001277200A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-cad protein and related reagents and methods of use thereof
|
EP1657254A3
(en)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
EP1315431A1
(en)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
A human gtp-releasing factor family member (15368) and uses therefor
|
WO2002010217A2
(en)
|
2000-08-02 |
2002-02-07 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
WO2002012330A2
(en)
*
|
2000-08-04 |
2002-02-14 |
Zymogenetics, Inc. |
Human secreted protein, zzp1
|
US6943245B2
(en)
|
2000-08-10 |
2005-09-13 |
Board Of Regents, The University Of Texas System |
Tumor suppressor CAR-1
|
JP2004506422A
(ja)
*
|
2000-08-11 |
2004-03-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
新規マイトジェン活性化キナーゼ
|
EP1326985A1
(en)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification of a human n-terminal acetyltransferase gene
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
JP2004519217A
(ja)
*
|
2000-08-21 |
2004-07-02 |
インサイト・ゲノミックス・インコーポレイテッド |
微小管関連タンパク質およびチューブリン
|
WO2002016579A2
(en)
*
|
2000-08-24 |
2002-02-28 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
CA2705366A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
CA2420902A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Craig A. Rosen |
18 human secreted proteins
|
AU2001284176A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Astrazeneca Ab |
Molecules involved in the regulation of insulin in resistance syndrome (irs)
|
AU2002210464A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
WO2002018577A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
48921, a novel human gtp releasing factor and uses therefor
|
WO2002018552A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
AU2001286714A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
54370, a novel human sulfate transporter and uses therefor
|
WO2002018582A2
(en)
*
|
2000-08-31 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
US7153669B2
(en)
|
2000-09-05 |
2006-12-26 |
Amgen Inc. |
Nucleic acids encoding MK61 receptors
|
CA2421265A1
(en)
*
|
2000-09-05 |
2002-03-14 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
US20020142464A1
(en)
*
|
2000-09-08 |
2002-10-03 |
Millennium Pharmaceuticals, Inc. |
38646, a novel guanine nucleotide exchange factor and uses therefor
|
US6372468B1
(en)
*
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
US20040048245A1
(en)
*
|
2000-10-05 |
2004-03-11 |
Shimkets Richard A. |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
WO2002031126A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
WO2002031132A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Millennium Pharmaceuticals, Inc. |
8843, a human dual specificity phosphatase family member and uses therefor
|
US20020064831A1
(en)
*
|
2000-10-12 |
2002-05-30 |
The Texas A&M University System |
Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use
|
EP1474528A4
(en)
*
|
2000-10-13 |
2006-06-14 |
Protein Design Labs Inc |
METHODS FOR DIAGNOSING PROSTATE CANCER, COMPOSITIONS AND METHODS FOR SCREENING PROSTATE CANCER MODULATORS
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
WO2002062945A2
(en)
|
2000-10-25 |
2002-08-15 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
WO2002036781A2
(en)
*
|
2000-10-31 |
2002-05-10 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
WO2002038743A2
(en)
*
|
2000-11-09 |
2002-05-16 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
EP1349934A2
(en)
|
2000-11-20 |
2003-10-08 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
AU2001297765A1
(en)
*
|
2000-12-05 |
2002-10-21 |
Incyte Genomics, Inc. |
Ligases
|
US7776523B2
(en)
|
2000-12-07 |
2010-08-17 |
Novartis Vaccines And Diagnostics, Inc. |
Endogenous retroviruses up-regulated in prostate cancer
|
EP1339845A2
(en)
|
2000-12-07 |
2003-09-03 |
ZymoGenetics, Inc. |
Adipocyte complemented related protein zacrp3x2
|
WO2002048328A2
(en)
*
|
2000-12-14 |
2002-06-20 |
Pe Corporation (Ny) |
Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
IL155687A0
(en)
|
2000-12-22 |
2003-11-23 |
Bristol Myers Squibb Co |
Polynucleotides encoding hlrrsi1 polypeptides
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US6423521B1
(en)
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
WO2002053591A1
(en)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Mammalian nuclear receptor cofactor cf12 and methods of use
|
US20030219739A1
(en)
*
|
2001-01-30 |
2003-11-27 |
Glass David J. |
Novel nucleic acid and polypeptide molecules
|
WO2002098917A2
(en)
*
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Human proteins and nucleic acids encoding same
|
EP1637601A3
(en)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
AU2002250143A1
(en)
*
|
2001-03-16 |
2002-10-03 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
AU2002258626B2
(en)
|
2001-04-10 |
2007-01-18 |
Agensys, Inc. |
Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
|
EP2280030A3
(en)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
EP1573022B1
(en)
|
2001-04-10 |
2011-06-08 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
|
WO2002086113A2
(en)
*
|
2001-04-24 |
2002-10-31 |
Isis Innovation Ltd |
Enzyme and snp marker for disease
|
JPWO2002088175A1
(ja)
*
|
2001-04-24 |
2004-08-19 |
大塚製薬株式会社 |
クローン病抗体結合性ペプチド及びクローン病の検査方法
|
KR100882762B1
(ko)
|
2001-05-07 |
2009-02-09 |
시오노기세이야쿠가부시키가이샤 |
혈관신생 마커로서 사용되는 폴리펩티드 및 이의 dna
|
AU2002314048A1
(en)
*
|
2001-05-09 |
2002-11-18 |
Bayer Aktiengesellschaft |
Regulation of human phosphatidic acid phosphatase type 2c-like protein
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2003000901A2
(en)
*
|
2001-06-26 |
2003-01-03 |
Decode Genetics Ehf. |
Nucleic acids encoding protein kinases
|
US20030120040A1
(en)
|
2001-06-29 |
2003-06-26 |
Genentech, Inc. |
Secreted and Transmembrane polypeptides and nucleic acids encoding the same
|
GB2399086A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ4
|
WO2003031568A2
(en)
*
|
2001-08-17 |
2003-04-17 |
Incyte Genomics, Inc. |
Intracellular signaling molecules
|
US7270960B2
(en)
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
WO2003023063A1
(fr)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Methode d'estimation du risque d'apparition de diabetes
|
WO2003025175A2
(fr)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
WO2003040369A2
(fr)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
CA2417455C
(en)
|
2001-09-28 |
2008-01-29 |
Brigham Young University |
Novel cyclooxygenase variants and methods of use
|
WO2003038087A1
(fr)
|
2001-10-04 |
2003-05-08 |
Kansai Technology Licensing Organization Co., Ltd. |
Promoteur du gene dr5 et promoteur du gene siah-1
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
WO2003031607A1
(en)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation of human short-chain dehydrogenase/reductase
|
DE60220621T2
(de)
|
2001-11-09 |
2008-03-06 |
Proteologics, Inc. |
Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
|
AU2002365162A1
(en)
|
2001-11-14 |
2003-07-09 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
CA2468145A1
(en)
*
|
2001-11-21 |
2003-05-30 |
Japan Science And Technology Agency |
Transcriptional factors for the huntington's disease gene
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
AU2002339697A1
(en)
*
|
2001-12-19 |
2003-06-30 |
Genset S.A. |
Gmg-5 polynucleotides and polypeptides and uses thereof
|
JP2003245084A
(ja)
*
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
|
DE10163467A1
(de)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
Protein 24B2 und zugrundliegende DNA-Sequenz
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
WO2003057870A1
(en)
*
|
2002-01-07 |
2003-07-17 |
Bayer Healthcare Ag |
Human phosphatidic acid phosphatase type 2-like protein
|
AU2003235631A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Bayer Aktiengesellschaft |
Human subtilisin/kexin-like convertase
|
AU2003205611A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Medigene Ag |
Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
|
WO2003062429A1
(fr)
*
|
2002-01-23 |
2003-07-31 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouvelle serine protease
|
US7371719B2
(en)
|
2002-02-15 |
2008-05-13 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
EP1338609A1
(de)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
Ein weiterer KDR Rezeptor und seine Anwendung
|
CA2478271A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Applera Corporation |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
GB2388113A
(en)
*
|
2002-03-06 |
2003-11-05 |
Oxford Glycosciences |
B-cell malignancy-associated protein
|
DK1918386T3
(da)
|
2002-03-13 |
2012-01-02 |
Genomic Health Inc |
Genekspressionsprofiler i biopsier af tumorvæv
|
AU2003220913A1
(en)
*
|
2002-03-19 |
2003-09-29 |
Tanabe Seiyaku Co., Ltd. |
Novel g protein-coupled recepotrs and genes thereof
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
US7329502B2
(en)
|
2002-04-25 |
2008-02-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
|
JP2004041003A
(ja)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
新規タンパク質、そのdnaおよびその用途
|
EP2275118A3
(en)
|
2002-05-29 |
2011-10-19 |
DeveloGen Aktiengesellschaft |
Pancreas-specific proteins
|
AU2003237367A1
(en)
|
2002-06-03 |
2003-12-19 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
DK1513934T3
(da)
|
2002-06-06 |
2011-05-02 |
Oncotherapy Science Inc |
Gener og polypeptider relateret til humane coloncancersygdomme
|
JP2005535308A
(ja)
|
2002-06-13 |
2005-11-24 |
カイロン コーポレイション |
Hml−2ポリペプチド発現用ベクター
|
AU2003281626A1
(en)
*
|
2002-07-22 |
2004-02-09 |
Masayoshi Harigai |
Novel gene associated with rheumatoid arthritis
|
JP4186004B2
(ja)
|
2002-08-14 |
2008-11-26 |
独立行政法人産業技術総合研究所 |
新規n−アセチルガラクトサミン転移酵素およびそれをコードする核酸
|
AU2003243151A1
(en)
*
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
WO2004018518A1
(ja)
*
|
2002-08-23 |
2004-03-04 |
Japan Science And Technology Agency |
ヒト固形癌抗原ペプチドとこれをコードするポリヌクレオチド、並びにそれらの利用
|
AU2003250989A1
(en)
*
|
2002-08-27 |
2004-03-19 |
Epigenomics Ag |
Method and nucleic acids for the analysis of breast cell proliferative disorders
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
CN1703524B
(zh)
*
|
2002-09-30 |
2010-04-07 |
肿瘤疗法科学股份有限公司 |
与人胰腺癌相关的基因和多肽
|
EP1552310A2
(en)
*
|
2002-10-17 |
2005-07-13 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
EP1570080A4
(en)
|
2002-11-15 |
2006-03-01 |
Genomic Health Inc |
GENE EXPRESSION PROFILING OF EGFR-POSITIVE CANCER DISEASE
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
WO2004070025A2
(en)
*
|
2003-02-05 |
2004-08-19 |
Juan Saus |
Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
EP1445614A1
(en)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
A method for the in vitro assessment of the progression status of an HIV virus in an invidual
|
US7074891B2
(en)
*
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
AU2004213871B9
(en)
|
2003-02-20 |
2009-09-03 |
Genomic Health, Inc. |
Use of intronic RNA to measure gene expression
|
WO2004078784A1
(ja)
*
|
2003-03-04 |
2004-09-16 |
Astellas Pharma Inc. |
線維化病態に関連する新規遺伝子
|
PL378582A1
(pl)
|
2003-03-19 |
2006-05-02 |
Biogen Idec Ma Inc. |
Białko wiążące receptor Nogo
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
EP3470535B1
(en)
|
2003-06-24 |
2020-04-01 |
Genomic Health, Inc. |
Prediction of likelihood of cancer recurrence
|
US7526387B2
(en)
|
2003-07-10 |
2009-04-28 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
ATE528397T1
(de)
|
2003-08-08 |
2011-10-15 |
Perseus Proteomics Inc |
Bei krebs überexprimiertes gen
|
US20050136434A1
(en)
*
|
2003-08-12 |
2005-06-23 |
Mai Xu |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
TW200517503A
(en)
*
|
2003-09-10 |
2005-06-01 |
Japan Science & Tech Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
EP1667712B1
(en)
*
|
2003-10-02 |
2010-07-21 |
GlaxoSmithKline Biologicals S.A. |
B. pertussis antigens and use thereof in vaccination
|
CA2541006C
(en)
|
2003-10-03 |
2015-02-17 |
Brigham And Women's Hospital |
Tim-3 polypeptides
|
WO2005040791A2
(en)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr)
|
US20050255560A1
(en)
*
|
2003-11-21 |
2005-11-17 |
Zeren Gao |
Ztnf11, a tumor necrosis factor
|
CA2549164A1
(en)
|
2003-12-05 |
2005-06-23 |
Northwestern University |
Self-assembling peptide amphiphiles and related methods for growth factor delivery
|
JP4718490B2
(ja)
|
2003-12-23 |
2011-07-06 |
ジェノミック ヘルス, インコーポレイテッド |
フラグメント化rnaの全般的増幅
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
PT3556866T
(pt)
|
2004-03-02 |
2021-04-30 |
Univ Johns Hopkins |
Mutações do gene de pik3ca em cancros humanos
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
WO2005090569A1
(en)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
|
WO2005095450A2
(en)
|
2004-03-30 |
2005-10-13 |
Nsgene A/S |
Therapeutic use of a growth factor, nsg33
|
DK2163650T3
(en)
|
2004-04-09 |
2015-11-02 |
Genomic Health Inc |
Genekspressionsmarkører for prediction of response to chemotherapy
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
WO2005118832A2
(en)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
|
AU2005258335B2
(en)
|
2004-06-24 |
2011-03-17 |
Biogen Ma Inc. |
Treatment of conditions involving demyelination
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
US7985831B2
(en)
*
|
2004-08-05 |
2011-07-26 |
Toagosei Co., Ltd. |
Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease
|
HUE051605T2
(hu)
|
2004-11-05 |
2021-03-01 |
Nsabp Found Inc |
Kemoterápiára adott válasz elõrejelzése génexpressziós markereket alkalmazva
|
CA2585561C
(en)
|
2004-11-05 |
2018-07-17 |
Genomic Health, Inc. |
Esr1, pgr, bcl2 and scube2 group score as indicators of breast cancer prognosis and prediction of treatment response
|
EP2845865A1
(en)
|
2004-11-12 |
2015-03-11 |
Xencor Inc. |
Fc variants with altered binding to FcRn
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
CA2598251A1
(en)
|
2005-03-04 |
2006-09-14 |
Northwestern University |
Angiogenic heparin binding peptide amphiphiles
|
WO2006120019A2
(en)
*
|
2005-05-13 |
2006-11-16 |
Centre National De La Recherche Scientifique |
Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
|
MX2008000253A
(es)
|
2005-07-08 |
2008-04-02 |
Biogen Idec Inc |
Anticuerpos de sp35 y usos de los mismos.
|
WO2007014338A2
(en)
*
|
2005-07-26 |
2007-02-01 |
Siemens Medical Solutions Diagnostics |
Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
|
WO2007037601A1
(en)
*
|
2005-09-28 |
2007-04-05 |
Knu-Industry Cooperation Foundation |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
DE602005023550D1
(de)
|
2005-12-14 |
2010-10-21 |
Licentia Ltd |
Verwendungen eines neurotrophischen Faktors
|
EP2044216A2
(en)
*
|
2006-07-03 |
2009-04-08 |
Exonhit Therapeutics SA |
Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
|
EP2066810A2
(en)
*
|
2006-09-08 |
2009-06-10 |
Corixa Corporation |
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
GB0805159D0
(en)
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
ES2553270T3
(es)
*
|
2007-07-27 |
2015-12-07 |
Immatics Biotechnologies Gmbh |
Nuevo epítopo inmunogénico para inmunoterapia
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
WO2009034661A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Method for diagnosis and induction of resistance to virus
|
ES2401233T3
(es)
|
2007-10-17 |
2013-04-18 |
Universidad de Córdoba |
Isoformas del receptor tipo 5 de somatostatina humana producidas por tratamiento alternativo y pares de oligonucleótidos para la detección de las mismas por PCR
|
HUE024903T2
(en)
|
2007-12-26 |
2016-02-29 |
Xencor Inc |
FC variants with modified binding to FCRN
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
ES2584438T3
(es)
|
2008-03-21 |
2016-09-27 |
Universiteit Hasselt |
Biomarcadores para artritis reumatoide
|
EP2315779A2
(en)
|
2008-07-09 |
2011-05-04 |
Biogen Idec MA Inc. |
Compositions comprising antibodies to lingo or fragments thereof
|
ATE531383T1
(de)
|
2008-07-24 |
2011-11-15 |
Nsgene As |
Therapeutische verwendung eines wachstumsfaktors, metrnl
|
ES2536465T3
(es)
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
|
CA2758687A1
(en)
|
2008-11-14 |
2010-05-20 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
WO2010062960A2
(en)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
|
WO2010066018A1
(en)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
|
WO2010120830A1
(en)
|
2009-04-13 |
2010-10-21 |
Northwestern University |
Novel peptide-based scaffolds for cartilage regeneration and methods for their use
|
WO2011028952A1
(en)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
ES2802623T3
(es)
|
2010-01-27 |
2021-01-20 |
Massachusetts Inst Technology |
Agentes polipeptídicos técnicamente diseñados para la neutralización dirigida de amplio espectro de la gripe
|
AU2011312417B2
(en)
|
2010-09-29 |
2015-08-20 |
Agensys, Inc. |
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
|
WO2012041328A1
(en)
|
2010-10-01 |
2012-04-05 |
Nsgene A/S |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
DK2651430T3
(en)
*
|
2010-12-14 |
2018-08-27 |
Hananja Ehf |
Biological activity of placental protein 13
|
US9474786B2
(en)
|
2011-09-05 |
2016-10-25 |
Nsgene A/S |
Treatment of allodynia
|
WO2013068445A1
(en)
*
|
2011-11-09 |
2013-05-16 |
Sanofi |
Diacylglycerol lipase and uses thereof
|
PT3489254T
(pt)
|
2012-04-30 |
2022-12-30 |
Biocon Ltd |
Proteínas de fusão direcionadas/imunomoduladoras e seus métodos de fabrico
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
CN104470541A
(zh)
|
2012-05-14 |
2015-03-25 |
比奥根艾迪克Ma公司 |
用于治疗涉及运动神经元的疾患的lingo-2拮抗剂
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
CN105073776B
(zh)
|
2012-11-13 |
2019-04-12 |
拜恩科技股份公司 |
用于治疗表达紧密连接蛋白的癌症疾病的制剂
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
US9023353B2
(en)
*
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
CA2908553A1
(en)
|
2013-03-27 |
2014-10-02 |
Cedars-Sinai Medical Center |
Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways
|
JP7019233B2
(ja)
|
2013-07-11 |
2022-02-15 |
モデルナティエックス インコーポレイテッド |
CRISPR関連タンパク質をコードする合成ポリヌクレオチドおよび合成sgRNAを含む組成物ならびに使用方法
|
WO2015010108A1
(en)
|
2013-07-19 |
2015-01-22 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
JP6915987B2
(ja)
|
2013-09-25 |
2021-08-11 |
シトムクス セラピューティクス,インコーポレイティド |
マトリックスメタロプロテイナーゼ基質及び他の切断可能部分並びにそれらの使用方法
|
CA2925658C
(en)
|
2013-10-01 |
2022-12-06 |
Mie University |
Long chain antigen containing interepitope sequence that promotes antigen presentation to t cells
|
IL302642A
(en)
|
2014-01-31 |
2023-07-01 |
Cytomx Therapeutics Inc |
Polypeptide substrates that activate matriptase and U-plasminogen and other cleavable groups, preparations containing them and their uses
|
JP2018504400A
(ja)
|
2015-01-08 |
2018-02-15 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
Lingo‐1拮抗薬及び脱髄障害の治療のための使用
|
MA41374A
(fr)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
|
EP3307070A4
(en)
*
|
2015-06-12 |
2019-01-02 |
Emory University |
Growth and survival compositions for cells capable of producing antibodies and methods related thereto
|
CN108138198B
(zh)
*
|
2015-09-04 |
2022-10-28 |
合成基因组股份有限公司 |
为提高的产率而改造的微生物
|
KR20180127416A
(ko)
|
2016-03-17 |
2018-11-28 |
세다르스-신나이 메디칼 센터 |
Rnaset2를 통한 염증성 장 질환의 진단 방법
|
US20200330606A1
(en)
*
|
2016-03-29 |
2020-10-22 |
Valkyrie Therapeutics Inc. |
Modulation of structural maintenance of chromosome-1 expression
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
EP3508499A1
(en)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof
|
AU2020261435A1
(en)
*
|
2019-04-26 |
2021-11-25 |
Sangamo Therapeutics, Inc. |
Engineering AAV
|
JP2022538688A
(ja)
|
2019-07-05 |
2022-09-05 |
イオックス セラピューティクス アーゲー |
IGSF11(VSIG3)のIgC2に結合する抗体及びその使用
|
WO2021083958A1
(en)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Novel peptides inducing satiety
|
EP4149952A1
(en)
*
|
2020-05-12 |
2023-03-22 |
Institut Curie |
Neoantigenic epitopes associated with sf3b1 mutations
|
WO2022008027A1
(en)
|
2020-07-06 |
2022-01-13 |
Iomx Therapeutics Ag |
Antibodies binding igv of igsf11 (vsig3) and uses thereof
|
CN117529492A
(zh)
*
|
2021-01-21 |
2024-02-06 |
鹿特丹伊拉斯谟大学医疗中心 |
用于治疗的t细胞
|
US20220260597A1
(en)
*
|
2021-02-18 |
2022-08-18 |
Beren Therapeutics P.B.C. |
Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
|
WO2023225602A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Interleukin-18 receptor binding polypeptides and uses thereof
|